Clinical Trial Update: Albumin-Bound Paclitaxel Combined With Carboplatin as Neoadjuvant Chemotherapy in Luminal B/HER-2 Negative Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating albumin-bound paclitaxel with carboplatin as neoadjuvant chemotherapy for luminal B/HER-2 negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Albumin-bound paclitaxel (nab-paclitaxel)
• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Fudan University | Conditions: HER-2 Negative Breast Cancer | Phase 4 | Status: UNKNOWN